Laparoscopic management and outcomes in non-functioning moieties of duplex kidneys in children.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 66
- Publication type:
- Article
Works matching IS 1759832X AND DT 2010 AND VI 2 AND IP 2
Results: 34
1
2
New strategies in kidney cancer: therapeutic advances through understanding the molecular basis of response and resistance.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 66
- Publication type:
- Article
3
Treating the individual: the need for a patient-focused approach to the management of renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 63
- Publication type:
- Article
4
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 65
- Publication type:
- Article
5
Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 62
- Publication type:
- Article
6
Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 61
- Publication type:
- Article
7
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 60
- Publication type:
- Article
8
Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 59
- Publication type:
- Article
9
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2 and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open label randomized trial.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 58
- Publication type:
- Article
10
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine and metronomic capecitabine) in metastatic renal-cell carcinoma: a Phase 2 study (SOGUG-02-06).
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 58
- Publication type:
- Article
11
Combination systemic therapy for advanced renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 57
- Publication type:
- Article
12
Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a Phase III trial: final results and geographical analysis.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 56
- Publication type:
- Article
13
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 55
- Publication type:
- Article
14
Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 54
- Publication type:
- Article
15
Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 54
- Publication type:
- Article
16
Pazopanib: therapeutic developments.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 52
- Publication type:
- Article
17
Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 53
- Publication type:
- Article
18
Pazopanib.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 51
- Publication type:
- Article
19
What is new in kidney cancer?
- Published in:
- 2010
- Publication type:
- Proceeding
20
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 49
- Publication type:
- Article
21
Effect of collecting duct histology on renal cell cancer outcome.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 48
- Publication type:
- Article
22
Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 47
- Publication type:
- Article
23
Amplification of epidermal growth factor receptor gene in renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 46
- Publication type:
- Article
24
Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 45
- Publication type:
- Article
25
Primary cell culture from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of annexin A3.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 43
- Publication type:
- Article
26
Expression of galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 45
- Publication type:
- Article
27
Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardiac decompensation with sunitinib malate therapy.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 43
- Publication type:
- Article
28
Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 42
- Publication type:
- Article
29
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 40
- Publication type:
- Article
30
Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 41
- Publication type:
- Article
31
Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 39
- Publication type:
- Article
32
International Events 2010.
- Published in:
- 2010
- Publication type:
- Calendar
33
Foreword.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 29
- Publication type:
- Article
34
Laparoscopy in the Treatment of Renal Cell Carcinoma: A Review of Long-Term Oncological Outcomes.
- Published in:
- Current Medical Literature: Kidney Cancer, 2010, v. 2, n. 2, p. 29
- By:
- Publication type:
- Article